Pfizer Receives U.S. FDA Approval for BESPONSA® (inotuzumab ozogamicin)
Go back to Pfizer Receives U.S. FDA Approval for BESPONSA® (inotuzumab ozogamicin)| Pfizer Inc. (NYSE: PFE) | Delayed: 27.88 -0.19 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.07 | 52 Week High | $37.39 | |||
| Open | $28.05 | 52 Week Low | $28.25 | |||
| Day High | $28.16 | P/E | 16.90 | |||
| Day Low | $27.87 | EPS | $1.65 | |||
| Volume | 1,496,357 | |||||
